| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |